首页> 外文OA文献 >An integrative genomic analysis of transcriptional profiles identifies characteristic genes and patterns in HIV-infected long-term non-progressors and elite controllers
【2h】

An integrative genomic analysis of transcriptional profiles identifies characteristic genes and patterns in HIV-infected long-term non-progressors and elite controllers

机译:转录型材的一致基因组分析鉴定了艾滋病毒感染的长期非进展和精英控制器中的特征基因和模式

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Abstract Background Despite that most HIV-infected individuals experience progressive CD4+ T cell loss and develop AIDS, a minority of HIV-infected individuals remain asymptomatic and maintain high level CD4+ T cell counts several years after seroconversion. Efforts have been made to understand the determinants of the nonprogressive status, exemplified by the clinical course of elite controllers (ECs) who maintain an undetectable viremia and viremic nonprogressors (VNPs) who have a normal CD4+ count in spite of circulating viral load. However, the intrinsic mechanism underlying nonprogression remained elusive. In this study, we performed an integrative analysis of transcriptional profiles to pinpoint the underlying mechanism for a naturally occurring viral control. Methods Three microarray datasets, reporting mRNA expression of the LTNPs or ECs in HIV-infected patients, were retrieved from Gene Expression Ominbus (GEO) or Arrayexpress databases. These datasets, profiled on the same type of microarray chip, were selected and merged by a bioinformatic approach to build a meta-analysis derived transcriptome (MADNT). In addition, we investigated the different transcriptional pathways and potential biomarkers in CD4+ and CD8+ cells in ECs and whole blood in VNPs compared to HIV progressors. The combined transcriptome and each subgroup was subject to gene set enrichment analysis and weighted co-expression network analysis to search potential transcription patterns related to the non-progressive status. Results 30 up-regulated genes and 83 down-regulated genes were identified in lymphocytes from integrative meta-analysis of expression data. The interferon response and innate immune activation was reduced in both CD4+ and CD8+ T cells from ECs. Several characteristic genes including CMPK1, CBX7, EIF3L, EIF4A and ZNF395 were indicated to be highly correlated with viremic control. Besides that, we indicated that the reduction of ribosome components and blockade of translation facilitated AIDS disease progression. Most interestingly, among VNPs who have a relatively high viral load, we detected a two gene-interaction networks which showed a strong correlation to immune control even with a rigorous statistical threshold (p value = 2−e4 and p value = 0.004, respectively) by WGCNA. Conclusions We have identified differentially expressed genes and transcriptional patterns in ECs and VNPs compared to normal chronic HIV-infected individuals. Our study provides new insights into the pathogenesis of HIV and AIDS and clues for the therapeutic strategies for anti-retroviral administration.
机译:摘要背景尽管大多数HIV感染者经历渐进的CD4 + T细胞丧失和发展为艾滋病,HIV感染的少数人没有症状,并保持较高水平的CD4 + T细胞计数转阴经过几年。已经做出努力来了解的非进行性状态的决定因素,由临床过程精英控制器(ECS)谁保持检测不到的病毒血症和病毒血症进展者(VNPs)谁具有正常CD4 +尽管循环病毒载量的计数举例说明。然而,固有的内在机制非进展仍然难以捉摸。在这项研究中,我们进行的转录概况的综合分析以查明对于天然存在的病毒控制的基本机制。方法三微阵列数据,报告的艾滋病毒感染患者的LTNPs或内皮细胞的mRNA的表达,从基因表达Ominbus(GEO)或Arrayexpress数据库检索。这些数据集,异形上相同类型的微阵列芯片的,选择和合并由生物信息学的方法来建立一个荟萃分析衍生的转录组(MADNT)。此外,我们研究了内皮细胞和全血中CD4 +和CD8不同的转录途径和潜在生物标志物+细胞VNPs相比,HIV进展者。将合并的转录和每个子组有待基因组富集分析和加权共表达网络分析以搜索相关的非渐进状态潜在的转录模式。结果30上调的基因和83下调的基因中从表达数据的综合荟萃分析的淋巴细胞进行了鉴定。干扰素应答和先天免疫活化在内皮细胞CD4 +和CD8 + T细胞减少。被指示的几个特性的基因包括CMPK1,CBX7,EIF3L,EIF4A和ZNF395与病毒血症的控制高度相关。此外,我们表明,核糖体成分和翻译的封锁的减少有利于艾滋病病情进展。最有趣的是,VNPs谁具有相对高的病毒载量之间,我们检测到两个基因的交互网络,其中(分别为p值= 2-E4和P值= 0.004)显示出对免疫控制的强相关性,即使在严格的统计学阈通过WGCNA。结论相比普通慢性HIV感染者我们已经确定了差异表达的基因和转录模式中的EC和VNPs。我们的研究提供了新的见解艾滋病毒和艾滋病和线索的发病机制为抗逆转录病毒给药的治疗策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号